Results 11 to 20 of about 1,085,685 (349)

Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines

Human Vaccines & Immunotherapeutics, 2020
Simultaneous administration of different vaccines is a strategy to increase the possibility to receive vaccines at appropriate age, safely and effectively, reducing the number of sessions and allowing a more acceptable integration of new vaccines into ...
Paolo Bonanni, Sara Boccalini, Angela Bechini, Ornella Varone, Giulio Matteo, Federica Sandri, Giovanni Gabutti   +6 more
doaj   +2 more sources

Strengths and weaknesses of pneumococcal conjugate vaccines

Glycoconjugate Journal, 2023
Multivalent vaccines addressing an increasing number of Streptococcus pneumoniae types (7-, 10-, 13-, 15-, 20-valent) have been licensed over the last 22 years.
F. Micoli, M. Romano, F. Carboni, R. Adamo, F. Berti   +4 more
semanticscholar   +1 more source

Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines.

ACS Infectious Diseases, 2023
The surface of cells is coated with a dense layer of glycans, known as the cell glycocalyx. The complex glycans in the glycocalyx are involved in various biological events, such as bacterial pathogenesis, protection of bacteria from environmental ...
Rajendra S Rohokale, Zhongwu Guo
semanticscholar   +1 more source

Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe

Emerging Infectious Diseases, 2022
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vaccine (PCV) programs using 10-valent (PCV10) and 13-valent (PCV13) vaccines in 10 countries in Europe.
G. Hanquet, P. Krizova, T. Dalby, S. Ladhani, J. P. Nuorti, K. Danis, J. Mereckiene, M. Knol, B. Winje, P. Ciruela, S. de Miguel, M. Portillo, L. MacDonald, E. Morfeldt, J. Kozáková, P. Valentiner-Branth, N. Fry, H. Rinta-Kokko, E. Varon, M. Corcoran, A. van der Ende, D. Vestrheim, C. Muñoz-Almagro, J. Sanz, J. Castilla, Andrew Smith, B. Henriques‐Normark, E. Colzani, L. Pastore-Celentano, C. Savulescu   +29 more
semanticscholar   +1 more source

On-demand biomanufacturing of protective conjugate vaccines

Science Advances, 2021
In vitro conjugate vaccine expression technology enables rapid and portable biosynthesis of protective antibacterial vaccines. Conjugate vaccines are among the most effective methods for preventing bacterial infections.
Jessica C. Stark, Thapakorn Jaroentomeechai, Tyler D Moeller, Jasmine M. Hershewe, Katherine F. Warfel, Bridget S. Moricz, A. M. Martini, Rachel S Dubner, Karen J. Hsu, T. Stevenson, B. Jones, M. DeLisa, M. Jewett   +12 more
semanticscholar   +1 more source

Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses

Science Translational Medicine, 2022
Streptococcus pneumoniae is a major cause of community-acquired pneumonia, bacteremia, and meningitis in older adults worldwide. Two pneumococcal vaccines containing S.
Leela R. L. Davies, D. Cizmeci, Wenyue Guo, Corinne Luedemann, Ronika Alexander-Parrish, L. Grant, R. Isturiz, C. Theilacker, L. Jodar, B. Gessner, G. Alter   +10 more
semanticscholar   +1 more source

Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe

Journal of Infectious Diseases, 2021
Pneumococcal conjugate vaccine (PCV) has reduced the burden of pneumococcal disease by the near elimination of vaccine serotypes from countries giving a booster dose at >9 months of life.
G. Rodgers, C. Whitney, K. Klugman
semanticscholar   +1 more source

Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines

Human Vaccines & Immunotherapeutics, 2021
The universal administration of pneumococcal conjugate vaccines (PCVs) had been demonstrated as an effective way to prevent Streptococcus pneumoniae infection.
Qian-qian Du, W. Shi, Dan Yu, K. Yao
semanticscholar   +1 more source

Changing Epidemiology of Bacterial Meningitis Since Introduction of Conjugate Vaccines: 3 Decades of National Meningitis Surveillance in The Netherlands

Clinical Infectious Diseases, 2020
Background The epidemiology of acute bacterial meningitis has changed substantially since the introduction of conjugate vaccines. Methods We analyzed nationwide surveillance data of all cerebrospinal fluid isolates received by the Netherlands Reference ...
D. Koelman, Merel N. van Kassel, M. Bijlsma, M. Brouwer, D. van de Beek, A. van der Ende   +5 more
semanticscholar   +1 more source

Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication

Expert Review of Vaccines, 2020
Introduction Prior to implementation of Haemophilus influenzae type b (Hib)-conjugate vaccination programs in the 1990s, Hib was the commonest cause of bacterial meningitis in children aged 29,000 deaths worldwide in children aged
M. Slack, S. Esposito, H. Haas, A. Mihályi, M. Nissen, Piyali Mukherjee, L. Harrington   +6 more
semanticscholar   +1 more source